Memodent Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Memodent Group - overview
Established
2001
Location
Athens, -, Greece
Primary Industry
Medical Devices & Equipment
About
Based in Greece, Memodent Group supplies dental products and services, supporting dental professionals with essential tools for restorative and orthodontic procedures through high-quality offerings. Memodent Group, founded in 2001, is based in Athens, Greece, and focuses on providing dental products to professionals in the dental industry. The company has not undergone any notable pivots or structural changes since its inception. It operates independently and has not been reported to have subsidiaries or a parent company.
The founder's background is not specified. Memodent has been involved in 1 deal, with the most recent deal occurring on January 20, 2026. Memodent specializes in providing a comprehensive range of dental products and services designed to support dental professionals in various restorative and orthodontic procedures. Their core offerings include dental materials such as flowable composites, dental chairs, and various tools and instruments essential for dental practice.
These products are engineered to enhance the precision and efficiency of treatments, addressing common challenges faced by practitioners when restoring dental functions. The company serves a diverse client base, including dental clinics, orthodontists, and dental laboratories, providing them with high-quality materials that facilitate effective patient care. Memodent's products are marketed across several international regions, including Europe and Asia, highlighting their commitment to catering to a global market demanding advanced dental solutions. Memodent generates revenue through direct sales of its dental products and supplies to dental professionals and clinics.
The typical business transaction structure involves B2B interactions where dental practices place orders for various products, including flagship items such as 3M™ Filtek™ composites and advanced imaging systems like the DENTSPLY SIRONA PRIMESCAN. Pricing strategies are designed to accommodate bulk purchasing typical in the dental industry, with discounts applied to larger orders, thereby incentivizing clinics to maintain stock of essential materials. The company also fosters relationships with distributors and partners to enhance market reach, ensuring consistent availability of its products in key geographical markets. As such engagements grow, they bolster the company's position within the competitive dental supply landscape.
On January 20, 2026, Memodent Group was acquired by Dental Investments Holding, a portfolio company of Abris Capital Partners, although the financial terms were not disclosed. This acquisition is projected to expand Dental Investments Holding's dental portfolio and facilitate the next phase of growth. The company plans to introduce new products and expand into specific markets, although details on the upcoming products and targeted regions are not provided.
Current Investors
Dental Investments Holding
Primary Industry
Medical Devices & Equipment
Sub Industries
Dental Products & Services, Medical Devices & Equipment
Website
www.memodent.gr
Verticals
E-commerce, Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Memodent Group - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 3,973,342.4 | 4,197,074.8 | 3,872,535.3 | 4,188,565.7 | 4,543,539.6 | 5,291,124.9 | - | - | - |
| % Revenue Growth (YoY) | - | 5.6% | (7.7%) | 8.2% | 8.5% | 16.5% | - | - | - |
| EBITDA (USD) | 315,658.7 | 366,006.9 | 185,460.9 | 63,130.6 | 362,757.7 | 419,939.5 | - | - | - |
| Operating Income (USD) | 313,806 | 366,006.9 | 185,460.9 | 56,556 | 355,450.2 | 378,681.4 | - | - | - |
| Operating Margin | 7.9% | 8.7% | 4.8% | 1.4% | 7.8% | 7.2% | - | - | - |
| % EBITDA Margin | 7.9% | 8.7% | 4.8% | 1.5% | 8.0% | 7.9% | - | - | - |
| NET Income (USD) | 227,627.2 | 254,404.7 | 125,193.8 | 34,144.8 | 255,323.6 | 283,983 | - | - | - |
| % Net Margin | 5.7% | 6.1% | 3.2% | 0.8% | 5.6% | 5.4% | - | - | - |
Memodent Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Memodent Group | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.